Americas (WHO region) vs Jordan: Confirmed cases of MDR-TB started treatment for MDR-TB
Americas (WHO region)
92.0%
in 2012
Jordan
100.0%
in 2012
Americas (WHO region) rank
2nd
Jordan rank
3rd
Confirmed cases of MDR-TB started treatment for MDR-TB over time
- Americas (WHO region)
- Jordan
How they compare
Jordan currently reports 100.0% against 92.0% in Americas (WHO region), a difference of 8.0%.
That makes Jordan's figure about 1.1 times Americas (WHO region)'s.
Across all 5 years both countries report, Jordan has been ahead every year.
Americas (WHO region) ranks 2nd and Jordan ranks 3rd of 10 groups.
Jordan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Americas (WHO region) | Jordan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 101.0% | 106.5% | 5.5% | Jordan |
| 2010s | 88.0% | 100.0% | 12.0% | Jordan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher confirmed cases of mdr-tb started treatment for mdr-tb, Americas (WHO region) or Jordan?
- Jordan, at 100.0% against 92.0% in Americas (WHO region) as of 2012.
- What is the difference in confirmed cases of mdr-tb started treatment for mdr-tb between Americas (WHO region) and Jordan?
- 8.0%, with Jordan ahead.
- How many years of comparable data are there for Americas (WHO region) and Jordan?
- 5 years are reported by both, from 2008 to 2012.
- How do Americas (WHO region) and Jordan rank globally for confirmed cases of mdr-tb started treatment for mdr-tb?
- Americas (WHO region) ranks 2nd and Jordan ranks 3rd of 10 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Confirmed cases of MDR-TB started treatment for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.